Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 20;5(1):1-10.
doi: 10.5493/wjem.v5.i1.1.

Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options

Cecilia Söderberg-Nauclér  1 , John Inge Johnsen  1
Affiliations
Review

Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options

Cecilia Söderberg-Nauclér et al. World J Exp Med. .

Abstract

During the last years increasing evidence implies that human cytomegalovirus (CMV) can be attributed to human malignancies arising from numerous tissues. In this perspective, we will review and discuss the potential mechanisms through which CMV infection may contribute to brain tumors by affecting tumor cell initiation, progression and metastasis formation. Recent evidence also suggests that anti-CMV treatment results in impaired tumor growth of CMV positive xenografts in animal models and potentially increased survival in CMV positive glioblastoma patients. Based on these observations and the high tumor promoting capacity of this virus, the classical and novel antiviral therapies against CMV should be revisited as they may represent a great promise for halting tumor progression and lower cancer deaths.

Keywords: Brain tumor; Cytomegalovirus; Glioblastoma; Medulloblastoma; Oncovirus.

PubMed Disclaimer

References

    1. Mocarski E, Shenk TR, P . Cytomegaloviruses. In: Knipe D, Howley P, editors. Fields Virology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. pp. 2701–2772.
    1. Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA. 1989;261:3607–3609. - PubMed
    1. Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, Vimalachandra D, Craig JC. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet. 2005;365:2105–2115. - PubMed
    1. Freeman RB. The ‘indirect’ effects of cytomegalovirus infection. Am J Transplant. 2009;9:2453–2458. - PubMed
    1. Razonable R. Direct and indirect effects of cytomegalovirus: can we prevent them? Enferm Infecc Microbiol Clin. 2010;28:1–5. - PubMed

LinkOut - more resources